160 related articles for article (PubMed ID: 38448817)
1. A case report of youth-onset lipoprotein glomerulopathy with APOE Chicago mutation.
Liu Y; Cheng Y; Wen Y; Li C; Chen G; Li M
BMC Nephrol; 2024 Mar; 25(1):87. PubMed ID: 38448817
[TBL] [Abstract][Full Text] [Related]
2. The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
Wu H; Yang Y; Hu Z
J Atheroscler Thromb; 2018 Aug; 25(8):733-740. PubMed ID: 29398675
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America.
da Silveira-Neto JN; de Oliveira Ahn GJ; de Menezes Neves PDM; Baptista VAF; de Almeida Araújo S; Wanderley DC; Watanabe A; Watanabe EH; Murai NM; Bertollo EMG; Vieira-Neto OM; Dantas M; de Antônio SR; Costa RS; Baptista MASF; Moysés-Neto M; Onuchic LF
Diagn Pathol; 2021 Jul; 16(1):65. PubMed ID: 34311745
[TBL] [Abstract][Full Text] [Related]
4. A Case of Lipoprotein Glomerulopathy with apoE Chicago and apoE (Glu3Lys) Treated with Fenofibrate.
Kodera H; Mizutani Y; Sugiyama S; Miyata T; Ehara T; Matsunaga A; Saito T
Case Rep Nephrol Dial; 2017; 7(2):112-120. PubMed ID: 28966924
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein glomerulopathy resulting from compound heterogeneous mutations of APOE gene: A case report.
Li Y; Chen J; Zou Y; Wang W; Li G
Medicine (Baltimore); 2022 Feb; 101(5):e28718. PubMed ID: 35119017
[TBL] [Abstract][Full Text] [Related]
6. A novel apolipoprotein E mutation caused by a five amino acid deletion in a Chinese family with lipoprotein glomerulopathy: a case report.
Xie W; Xie Y; Lin Z; Xu X; Zhang Y
Diagn Pathol; 2019 May; 14(1):41. PubMed ID: 31092271
[TBL] [Abstract][Full Text] [Related]
7. Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy.
Luo B; Huang F; Liu Q; Li X; Chen W; Zhou SF; Yu X
Am J Nephrol; 2008; 28(2):347-53. PubMed ID: 18046082
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations.
Yang M; Weng Q; Pan X; Hussain HMJ; Yu S; Xu J; Yu X; Liu Y; Jin Y; Zhang C; Li X; Ren H; Chen N; Xie J
Mol Genet Genomic Med; 2020 Aug; 8(8):e1281. PubMed ID: 32441489
[TBL] [Abstract][Full Text] [Related]
9. A young Chinese man with nephrotic syndrome due to lipoprotein glomerulopathy.
Lui DTW; Lee ACH; Yap DYH; Chan GSW; Tan KCB
J Clin Lipidol; 2019; 13(2):251-253. PubMed ID: 30685233
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report.
Kato J; Okonogi H; Kanzaki G; Katsumata H; Nakada Y; Sagasaki M; Komine K; Ito K; Saito T; Matsunaga A; Tokutou K; Honda K; Tsuboi N; Yokoo T
BMC Nephrol; 2024 May; 25(1):171. PubMed ID: 38769490
[TBL] [Abstract][Full Text] [Related]
11. A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.
Mitani A; Ishigami M; Watase K; Minakata T; Yamamura T
J Atheroscler Thromb; 2011; 18(6):531-5. PubMed ID: 21325775
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy.
Qin Y; Sun XJ; Hu YF; Jing M; Yu XJ; Zhao MH; Tan Y
Ren Fail; 2024 Dec; 46(1):2332491. PubMed ID: 38584145
[TBL] [Abstract][Full Text] [Related]
13. Common apolipoprotein E gene mutations contribute to lipoprotein glomerulopathy in China.
Han J; Pan Y; Chen Y; Li X; Xing G; Shi J; Hou P; Zhang H; Wang H
Nephron Clin Pract; 2010; 114(4):c260-7. PubMed ID: 20090368
[TBL] [Abstract][Full Text] [Related]
14. A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy.
Toyota K; Hashimoto T; Ogino D; Matsunaga A; Ito M; Masakane I; Degawa N; Sato H; Shirai S; Umetsu K; Tamiya G; Saito T; Hayasaka K
J Hum Genet; 2013 May; 58(5):254-8. PubMed ID: 23407349
[TBL] [Abstract][Full Text] [Related]
15. A novel apolipoprotein E mutation, ApoE Ganzhou (Arg43Cys), in a Chinese son and his father with lipoprotein glomerulopathy: two case reports.
Wang R; Zhao C; Chen W; Liu Z; Xie F
J Med Case Rep; 2022 Feb; 16(1):78. PubMed ID: 35193676
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3.
Chang CF; Lin CC; Chen JY; Yang AH; Shiao MS; Kao JT; Yang WC
Am J Kidney Dis; 2003 Sep; 42(3):E18-23. PubMed ID: 12955707
[TBL] [Abstract][Full Text] [Related]
17. Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.
Saito T; Ishigaki Y; Oikawa S; Yamamoto TT
Trends Cardiovasc Med; 2002 Feb; 12(2):67-70. PubMed ID: 11852253
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic features of lipoprotein glomerulopathy: observation of 6 cases].
Zou GM; Zhuo L; Tan M; Li WG
Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2910-2913. PubMed ID: 30293348
[No Abstract] [Full Text] [Related]
19. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
[TBL] [Abstract][Full Text] [Related]
20. Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy.
Ieiri N; Hotta O; Taguma Y
Am J Kidney Dis; 2003 Jan; 41(1):244-9. PubMed ID: 12500244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
